
Reset all filters
01 2Gowling WLG (Canada) LLP
Reset all filters
01 22723396
Reset all filters
01 2Dabrafenib Mesylate
Reset all filters
01 2Capsule
Reset all filters
01 22029-05-04
Patent Expiration Date : 2029-05-04
Date Granted : 2013-09-10
Brand Name : TAFINLAR
Patent Number : 2723396
Filing Date : 2009-05-04
Strength per Unit : 50 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2029-05-04
Date Granted : 2013-09-10
Patent Expiration Date : 2029-05-04
Date Granted : 2013-09-10
Brand Name : TAFINLAR
Patent Number : 2723396
Filing Date : 2009-05-04
Strength per Unit : 75 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2029-05-04
Date Granted : 2013-09-10